Ask AI
PURPOSE 1 and PURPOSE 2 Results in Adolescents and Young Adults
PURPOSE 1 and PURPOSE 2: Efficacy, Safety, and PK of Twice-Yearly Subcutaneous Lenacapavir for PrEP in Adolescents and Young Adults

Released: July 22, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: July 22, 2025